Source comparison
Comparison Table: Common BPC-157 Dosing Strategies
To make this clearer, our team put together a quick reference table. This is a generalized overview based on common practices in preclinical research and should not be taken as a directive, but as an illustrative guide. Acute Musculoskeletal Injury 5 – 10 mcg/
This comparison does not assign a generated winner or score.
- To make this clearer, our team put together a quick reference table. This is a generalized overview based on common practices in preclinical research and should not be taken as a directive, but as an illustrative guide.
- Acute Musculoskeletal Injury
- 5 – 10 mcg/kg
- 2 – 4 Weeks On
- Administration near the injury site (IM/SubQ) is common. The goal is rapid, targeted intervention.
- Chronic Gut Inflammation (IBD)
- 10 – 20 mcg/kg (Oral)
- 6 – 12 Weeks On
- Oral administration is preferred. Consistency is paramount. Longer off-cycles are needed to assess lasting change.
- General Systemic Repair
- 2 – 5 mcg/kg
- 4 – 8 Weeks On
- Subcutaneous injection is typical for systemic distribution. Often stacked with other peptides like TB-500.
- Tendon/Ligament Healing
- 6 – 8 Weeks On
- This is a slow process. Longer cycles are often required compared to muscle injuries. Patience is key.